DS Healthcare Launches Revita.LT High-Performance Hair-Stimulating Shampoo for Blond and Light Colors

Pompano Beach, May 28, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group Inc. (NASDAQ: DSKX), a leading developer of personal care products, announced today that it had extended its successful Revita hair-stimulating shampoo line to include new Revita.LT, formulated for blond and other light colors of hair. The company uses the latest advancements in biotechnology to deliver clinically proven results through nonprescription over-the-counter personal care products.

In a recent clinical study of Revita's effectiveness, 90 percent of volunteers reported less hair loss, 85 percent reported better appearance, 75 percent reported feeling cleaner, and 70 percent reported faster hair growth.

New Revita.LT, a shampoo for daily use on blond and other light colors, leaves hair soft, shiny, stronger, hydrated, and more beautiful. The formula remains free of sodium lauryl sulfate and sodium laureth sulfate, and it contains no ingredients linked to skin irritation, drying, hair stress, or thinning.

"Blond and highlighted hair colors have special needs and desires. Revita.LT delivers all the benefits of Revita plus unique additional benefits for light colors," stated the company's CEO, Daniel Khesin. "We are committed to delivering the best in biotechnology-driven personal care products, and we will continue to expand our product line to serve our customers better."

About DS Healthcare Group

DS Healthcare Group Inc. leads in the development of biotechnology for topical and nutritional therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its brands include DS Laboratories (www.DSLaboratories.com), Sigma Skin (www.SigmaSkin.com), Polaris Research Laboratories (www.PolarisReserachLabs.com), and The Pure Guild (www.ThePureGuild.com).

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control and may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, available at http://www.sec.gov

CONTACT: Contact: Laurel Moody Corporate Profile 1.646.810.0608 Source:DS Healthcare Group,Inc.